Comparison Between Recombinant Versus Urinary hCG for Ovulation Induction in High Responders
Unknown status
Eugonia
Phase 4
2013-06-01
The purpose of this study is to compare the clinical outcomes of recombinant human chorionic
gonadotrophin (rHCG) and urinary HCG (uHCG) in patients undergoing IVF cycles.
Comparison Between hCG and GnRH Agonist for Ovulation Induction in Patients With High Response to IVF Drugs
Unknown status
Eugonia
Phase 4
2003-11-01
hCG and GnRH agonist can be used to induce final oocyte maturation and ovulation in IVF
cycles. These two approaches will be compared in this study in terms of pregnancy rates and
embryological data using patients with hyper-response to IVF drugs.
Triggering of Final Oocyte Maturation With GnRHa (Buserelin) in GnRH Antagonist Cycles
Completed
Regionshospitalet Viborg, Skive
Phase 4
2009-01-01
The purpose of this study is to possibly further improve the clinical outcome and explore the
incidence of OHSS in patients, who have final oocyte maturation with GnRHa (Buserelin) in
GnRH antagonist IVF/ICSI cycles
Frozen Embryo Transfer (FET) in Natural Cycles or in Natural Cycles Controlled by Human Chorionic Gonadotropin (hCG) Administration
Completed
Universitair Ziekenhuis Brussel
N/A
2006-10-01
The rational of the study is to assess the implantation, pregnancy and live birth rates after
the transfer of frozen- thawed embryos in natural cycles with spontaneous Luteinizing Hormone
(LH)/Progesterone rise or in natural cycles controlled by human chorionic gonadotropin (hCG)
for final oocyte maturation and ovulation.
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
